The European Union's drug regulatory agency is looking into cases of blood clots among four individuals who received Johnson & Johnson's coronavirus vaccine, though a link between the two is not yet clear.
The European Medicines Agency (EMA) said Friday that serious cases of "unusual blood clots with low blood platelets" have been reported in four people who received the Johnson & Johnson inoculation.
Company response.
The company said in a statement shared with The Hill Friday that it was aware of the reports of blood clots and was working with regulators to review safety data.
"At present, no clear causal relationship has been established between these rare events and the Janssen COVID-19 vaccine," Johnson & Johnson said.
"The safety and well-being of the people who use our products is our number one priority," the vaccine developer added. "We share all adverse event reports about individuals receiving our COVID-19 vaccine, along with our assessment of these reports, with health authorities in compliance with regulatory standards."
Source. https://thehill.com/policy/healthcare/547463-eu-reviewing-johnson-johnson-vaccine-after-reports-of-rare-blood-clots
Hot Forum Topics
